JP2023552846A5 - - Google Patents

Info

Publication number
JP2023552846A5
JP2023552846A5 JP2023535046A JP2023535046A JP2023552846A5 JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5 JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5
Authority
JP
Japan
Prior art keywords
sequence
seq
antibody
antigen
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023535046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552846A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/084520 external-priority patent/WO2022122704A1/en
Publication of JP2023552846A publication Critical patent/JP2023552846A/ja
Publication of JP2023552846A5 publication Critical patent/JP2023552846A5/ja
Pending legal-status Critical Current

Links

JP2023535046A 2020-12-08 2021-12-07 メタニューモウイルスのｆ－タンパク質に結合する抗体およびその使用 Pending JP2023552846A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP2020085014 2020-12-08
EPPCT/EP2020/085014 2020-12-08
EPPCT/EP2020/085747 2020-12-11
EP2020085747 2020-12-11
PCT/EP2021/084520 WO2022122704A1 (en) 2020-12-08 2021-12-07 Antibodies binding to f-protein of metapneumovirus and uses thereof

Publications (2)

Publication Number Publication Date
JP2023552846A JP2023552846A (ja) 2023-12-19
JP2023552846A5 true JP2023552846A5 (enExample) 2024-11-22

Family

ID=78844890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535046A Pending JP2023552846A (ja) 2020-12-08 2021-12-07 メタニューモウイルスのｆ－タンパク質に結合する抗体およびその使用

Country Status (4)

Country Link
US (1) US20240034772A1 (enExample)
EP (1) EP4259654A1 (enExample)
JP (1) JP2023552846A (enExample)
WO (1) WO2022122704A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004215125B2 (en) 2003-02-26 2011-01-06 Institute For Research In Biomedicine Monoclonal antibody production by EBV transformation of B cells
NZ544924A (en) 2003-06-27 2009-03-31 Biogen Idec Inc Modified binding molecules comprising connecting peptides
JP4976376B2 (ja) * 2005-04-08 2012-07-18 メディミューン，エルエルシー 哺乳動物メタニューモウイルスに対する抗体
JP2010505876A (ja) * 2006-10-04 2010-02-25 ザ スクリプス リサーチ インスティテュート ヒトメタニューモウイルスを中和するヒト抗体
EP2158318A2 (en) 2007-05-14 2010-03-03 Biogen Idec MA, Inc. Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
PL2350128T3 (pl) 2008-10-22 2015-03-31 Inst Res Biomedicine Sposoby wytwarzania przeciwciał z komórek plazmatycznych
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
WO2016103238A1 (en) 2014-12-24 2016-06-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant metapneumovirus f proteins and their use
CN110035771B (zh) * 2016-10-21 2024-03-08 阿迪马布有限责任公司 抗呼吸道合胞病毒抗体及其产生和使用方法
WO2020236974A1 (en) * 2019-05-21 2020-11-26 University Of Georgia Research Foundation, Inc. Antibodies that bind human metapneumovirus fusion protein and their use

Similar Documents

Publication Publication Date Title
Scheid et al. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
JP7328479B2 (ja) 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途
JP7209464B2 (ja) ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体
JP6421371B2 (ja) トランスポーターに対する抗体およびその用途
JP2012518425A5 (enExample)
JP2005528914A5 (enExample)
JP2016529882A5 (enExample)
AU2015322141A1 (en) High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH
WO2019091449A1 (zh) Cd96抗体、其抗原结合片段及医药用途
JP2020515277A5 (enExample)
JP2017507131A5 (enExample)
WO2021212785A1 (zh) 一种全人源单克隆抗体及其应用
JP2023120385A (ja) ジストログリカンおよびラミニン２に対する特異性を有する多特異性結合性分子
JP2025507595A5 (enExample)
CN114591434A (zh) 抗Siglec15抗体及其制备方法和用途
JP2022528387A (ja) アビド結合多重特異性抗体を作製する方法
JPWO2022224997A5 (enExample)
JP2021515597A5 (enExample)
JP2024535124A5 (enExample)
KR20240031229A (ko) 알파-시누클레인병증 치료용 항체
JP2023552846A5 (enExample)
WO2021238854A1 (zh) 抗SARS-CoV-2刺突蛋白的单克隆抗体及其制备方法和用途
TWI867354B (zh) 新穎Nav1.7單株抗體
WO2020205504A1 (en) Common light chains and methods of use
CN115337396A (zh) 一种全人源单克隆抗体组合及其应用